Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression

被引:53
作者
Saporta, S
Cameron, DF
Borlongan, CV
Sanberg, PR
机构
[1] UNIV S FLORIDA,HLTH SCI CTR,COLL MED,DIV NEUROL SURG,TAMPA,FL 33612
[2] UNIV S FLORIDA,HLTH SCI CTR,COLL MED,DEPT SURG,DIV UROL,TAMPA,FL 33612
[3] UNIV S FLORIDA,HLTH SCI CTR,COLL MED,DEPT NEUROL,TAMPA,FL 33612
[4] UNIV S FLORIDA,HLTH SCI CTR,COLL MED,DEPT PHARMACOL,TAMPA,FL 33612
[5] UNIV S FLORIDA,HLTH SCI CTR,COLL MED,DEPT PSYCHIAT,TAMPA,FL 33612
[6] UNIV S FLORIDA,HLTH SCI CTR,COLL MED,DEPT PSYCHOL,TAMPA,FL 33612
关键词
D O I
10.1006/exnr.1997.6493
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The use of cyclosporine-A (CsA) immunosuppression for neural transplantation has become the treatment of choice for ameliorating host-graft rejection responses in human. and animal transplant studies. However, the cytotoxic effects of CsA have warranted a search for alternative methods of protecting neural transplants. Sertoli cells produce an immunosuppressant factor, Fas ligand (Fas-L), that may provide the testis with its immunoprivileged status. Therefore, it has recently been suggested that these cells may be useful in producing localized immunosuppression for transplants. If Sertoli cells do produce localized immunosuppression, then it should be possible to successfully transplant Sertoli cells without additional immunosuppression following transplant surgery. The present study was undertaken to determine whether rat or porcine Sertoli cells transplanted into rat brain would survive for an extended period of time without CsA immunosuppression. Isolated rat or porcine Sertoli cells prelabeled with DiI were transplanted into normal rat brain. We report that both rat Sertoli cell allografts and porcine Sertoli cell xenografts survived for at least 2 months posttransplantation into the rat brain without CsA immunosuppression, indicating that these grafts were capable of producing sufficient localized immunosuppression to survive at the site of transplant without additional systemic immunosuppression. (C) 1997 Academic Press.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 24 条
  • [1] ARAUJO DM, 1992, J NEUROSCI, V12, P1668
  • [2] BARKER CF, 1985, ADV IMMUNOL, V25, P1
  • [3] A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION
    BELLGRAU, D
    GOLD, D
    SELAWRY, H
    MOORE, J
    FRANZUSOFF, A
    DUKE, RC
    [J]. NATURE, 1995, 377 (6550) : 630 - 632
  • [4] Borlongan CV, 1996, NEUROL RES, V18, P297
  • [5] BREDEN JHM, 1985, LANCET, V26, P219
  • [6] BRUNDIN P, 1988, EXP BRAIN RES, V70, P192
  • [7] BRUNDIN P, 1985, EXP BRAIN RES, V60, P204
  • [8] CAMERON DF, 1987, ANN NY ACAD SCI, V513, P419
  • [9] UNUSUAL CYCLOSPORINE RELATED NEUROLOGICAL COMPLICATIONS IN RECIPIENTS OF LIVER-TRANSPLANTS
    CILIO, MR
    DANHAIVE, O
    GADISSEUX, JF
    OTTE, JB
    SOKAL, EM
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 68 (03) : 405 - 407
  • [10] DEGROEN C, 1984, NEW ENGL J MED, V317, P861